Christopher Astle - Net Worth and Insider Trading
Christopher Astle Net Worth
The estimated net worth of Christopher Astle is at least $54,723 dollars as of 2024-06-05. Christopher Astle is the SVP & CFO of Zymeworks Inc and owns about 6,503 shares of Zymeworks Inc (ZYME) stock worth over $54,723. Details can be seen in Christopher Astle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Astle has not made any transactions after 2024-01-08 and currently still holds the listed stock(s).
Transaction Summary of Christopher Astle
Christopher Astle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Astle owns 1 companies in total, including Zymeworks Inc (ZYME) .
Click here to see the complete history of Christopher Astle’s form 4 insider trades.
Insider Ownership Summary of Christopher Astle
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ZYME | Zymeworks Inc | 2024-01-08 | SVP & Chief Financial Officer |
Christopher Astle Latest Holdings Summary
Christopher Astle currently owns a total of 1 stock. Christopher Astle owns 6,503 shares of Zymeworks Inc (ZYME) as of January 8, 2024, with a value of $54,723.
Latest Holdings of Christopher Astle
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZYME | Zymeworks Inc | 2024-01-08 | 6,503 | 8.42 | 54,723 |
Holding Weightings of Christopher Astle
Christopher Astle Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Astle has made a total of 4 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Zymeworks Inc is the sale of 5,994 shares on January 8, 2024, which brought Christopher Astle around $64,675.
Insider Trading History of Christopher Astle
- 1
Christopher Astle Trading Performance
Christopher Astle Ownership Network
Ownership Network List of Christopher Astle
Ownership Network Relation of Christopher Astle
Christopher Astle Owned Company Details
What does Zymeworks Inc do?
Who are the key executives at Zymeworks Inc?
Christopher Astle is the SVP & Chief Financial Officer of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , Chief Scientific Officer Paul Andrew Moore , and 10 percent owner Ecor1 Capital, Llc .
Zymeworks Inc (ZYME) Insider Trades Summary
Over the past 18 months, Christopher Astle made 4 insider transaction in Zymeworks Inc (ZYME) with a net sale of 8,654. Other recent insider transactions involving Zymeworks Inc (ZYME) include a net purchase of 5,868,900 shares made by Ecor1 Capital, Llc , a net sale of 23,904 shares made by Kenneth Galbraith , and a net sale of 9,799 shares made by Paul Andrew Moore .
In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,334 shares of Zymeworks Inc (ZYME) were sold and 5,868,900 shares were bought by its insiders, resulting in a net purchase of 5,823,566 shares.
Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zymeworks Inc Insider Transactions
Christopher Astle Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Astle. You might contact Christopher Astle via mailing address: 114 East 4th Avenue, Suite 800, Vancouver A1 V5t 1g4.